Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Malignant Pericardial Mesothelioma With Constrictive Pericarditis Physiology Misdiagnosed as Pericardial Metastatic Cancer

  • Lee, Man-Jong (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Kim, Dae-Hyeok (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Kwan, Jun (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Park, Keum-Soo (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Shin, Sung-Hee (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Woo, Seoung-Il (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Park, Sang-Don (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Lee, Won-Seop (Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine)
  • Published : 2011.06.30
⟨ Previous Next ⟩

Abstract

Malignant pericardial mesothelioma is a rare and progressive cardiac tumor. There is no established standard treatment and the prognosis is poor. Most patients were retrospectively diagnosed from surgery or autopsy due to absence of specific clinical manifestation. Most patients with pericardial mesothelioma have demonstrated constrictive physiology on echocardiography or cardiac catheterization. Therefore, pericardial mesothelioma was often misdiagnosed as other causes of constrictive pericarditis. We report a case of primary pericardial mesothelioma misdiagnosed as pericardial metastasis of unknown origin.

Keywords

References

  1. Kralstein J, Frishman W. Malignant pericardial diseases: diagnosis and treatment. Am Heart J 1987;113:785-90. https://doi.org/10.1016/0002-8703(87)90720-4
  2. Gossinger HD, Siostrznek P, Zangeneh M, et al. Magnetic resonance imaging findings in a patient with pericardial mesothelioma. Am Heart J 1988;115:1321-2. https://doi.org/10.1016/0002-8703(88)90033-6
  3. Suman S, Schofield P, Large S. Primary pericardial mesothelioma pre-senting as pericardial constriction: case report. Heart 2004;90:e4. https://doi.org/10.1136/heart.90.1.e4
  4. Ha CB, Huh JY, Shin YW, Shin YK. Doppler flow patterns of const-rictive pericarditis. Korean Circ J 1989;19:47-54.
  5. Cherian G, Habashy A, Uthaman B, Cherian J, Salama A, Anim J. De-tection and follow-up of mediastinal lymph node enlargement in tuberculous pericardial effusions using computed tomography. Am J Med 2003;114:319-22. https://doi.org/10.1016/S0002-9343(02)01521-8
  6. Ha JW, Ko YG, Choi BW. Images in cardiology: delayed hyperenhan-cement of the pericardium by magnetic resonance imaging as a mar-ker of pericardial inflammation in a patient with tuberculous effusive constrictive pericarditis. Heart 2006;92:494.
  7. Kaminaga T, Takeshita T, Kimura I. Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. Eur Radiol 2003; 13(Suppl 6):L1-10.
  8. Flores RM, Akhurst T, Gonen M, et al. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2003; 126:11-6. https://doi.org/10.1016/S0022-5223(03)00207-1
  9. Ost P, Rottey S, Smeets P, Boterberg T, Stragier B, Goethals I. F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma. J Thorac Imaging 2008;23:35-8. https://doi.org/10.1097/RTI.0b013e318156eb39
  10. Lagrotteria DD, Tsang B, Elavathil LJ, Tomlinson CW. A case of primary malignant pericardial mesothelioma. Can J Cardiol 2005;21: 185-7.
  11. Kaul TK, Fields BJ, Kahn DR. Primary malignant pericardial mesothelioma: a case report and review. J Cardiovasc Surg (Torino) 1994; 35:261-7.
  12. Ceresoli GL, Zucali PA, Favaretto AG, et al. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol 2006;24:1443-8. https://doi.org/10.1200/JCO.2005.04.3190
  13. Kindler HL, Herndon JE, Zhang C, Green MR. Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. Lung Cancer 2005;48:423-8. https://doi.org/10.1016/j.lungcan.2004.12.002

Cited by

  1. Primary Pericardial Tumors vol.33, pp.6, 2011, https://doi.org/10.1148/rg.336135512
  2. Malignant pericardial mesothelioma : A systematic review of current practice vol.43, pp.1, 2011, https://doi.org/10.1007/s00059-016-4522-5
  3. Echocardiographic characteristics of primary malignant pericardial mesothelioma and outcomes analysis: a retrospective study vol.16, pp.1, 2011, https://doi.org/10.1186/s12947-018-0125-z